Literature DB >> 16824538

Simultaneous metal chelate affinity purification and endotoxin clearance of recombinant antibody fragments.

Timo Zimmerman1, Corinne Petit Frère, Marion Satzger, Monika Raba, Manuela Weisbach, Katrin Döhn, Andreas Popp, Mariel Donzeau.   

Abstract

Endotoxins are frequent contaminants of recombinant proteins produced in Escherichia coli. Due to their adverse effects, endotoxins have to be removed from recombinant proteins prior their use in cell-based assays or parenteral application. Reduction of endotoxin to less than 10 EU mg(-1) is, however, one of the most problematic steps during protein purification from E. coli and often associated with substantial loss of biological materials. The present paper describes the use of a single step procedure enabling metal chelate affinity purification and endotoxin clearance from antibody fragments produced in E. coli using a non-ionic detergent. Endotoxin content was as low as 5 to 9 EU mg(-1) with a recovery of antibody fragments of over 90%. Non-ionic detergent treatment did not compromise integrity and functionality of these multimeric molecules. Furthermore, recombinant antibody fragments did not stimulate endotoxin-sensitive cell lines confirming the low endotoxin content. In conclusion, this one-step protocol is a rapid, cost effective and automation-compatible procedure suitable for recombinant antibody fragments.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16824538     DOI: 10.1016/j.jim.2006.05.012

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  18 in total

1.  Experimental studies of a vaccine formulation of recombinant human VEGF antigen with aluminum phosphate.

Authors:  Lincidio Pérez Sánchez; Yanelys Morera Díaz; Mónica Bequet-Romero; Gerardo Ramses Hernández; Yadira Rodríguez; Jorge Castro Velazco; Pedro Puente Pérez; Marta Ayala Avila; Jorge V Gavilondo
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Antagonism of PDGF-BB suppresses subretinal neovascularization and enhances the effects of blocking VEGF-A.

Authors:  Aling Dong; Christopher Seidel; Daniel Snell; Savira Ekawardhani; Julia K J Ahlskog; Michael Baumann; Jikui Shen; Takeshi Iwase; Jing Tian; Rebecca Stevens; Sean F Hackett; Michael T Stumpp; Peter A Campochiaro
Journal:  Angiogenesis       Date:  2013-10-24       Impact factor: 9.596

3.  Leishmania phosphatase PP5 is a regulator of HSP83 phosphorylation and essential for parasite pathogenicity.

Authors:  Brianna Norris-Mullins; Joseph S Krivda; Kathryn L Smith; Micah J Ferrell; Miguel A Morales
Journal:  Parasitol Res       Date:  2018-07-08       Impact factor: 2.289

4.  Thermostable tag (TST) protein expression system: engineering thermotolerant recombinant proteins and vaccines.

Authors:  Jeremy M Luke; Aaron E Carnes; Ping Sun; Clague P Hodgson; David S Waugh; James A Williams
Journal:  J Biotechnol       Date:  2010-12-17       Impact factor: 3.307

5.  Eliciting Epitope-Specific CD8+ T Cell Response by Immunization with Microbial Protein Antigens Formulated with α-Galactosylceramide: Theory, Practice, and Protocols.

Authors:  Pavlo Gilchuk; Frances C Knight; John T Wilson; Sebastian Joyce
Journal:  Methods Mol Biol       Date:  2017

6.  Production of Vaccines Using Biological Conjugation.

Authors:  Emily J Kay; Vanessa S Terra
Journal:  Methods Mol Biol       Date:  2022

7.  A cytoplasmic negative regulator isoform of ATF7 impairs ATF7 and ATF2 phosphorylation and transcriptional activity.

Authors:  Jessica Diring; Barbara Camuzeaux; Mariel Donzeau; Marc Vigneron; Manuel Rosa-Calatrava; Claude Kedinger; Bruno Chatton
Journal:  PLoS One       Date:  2011-08-16       Impact factor: 3.240

8.  Combining cationic liposomal delivery with MPL-TDM for cysteine protease cocktail vaccination against Leishmania donovani: evidence for antigen synergy and protection.

Authors:  Amrita Das; Nahid Ali
Journal:  PLoS Negl Trop Dis       Date:  2014-08-21

9.  Highly potent VEGF-A-antagonistic DARPins as anti-angiogenic agents for topical and intravitreal applications.

Authors:  Andreas Stahl; Michael T Stumpp; Anja Schlegel; Savira Ekawardhani; Christina Lehrling; Gottfried Martin; Maya Gulotti-Georgieva; Denis Villemagne; Patrik Forrer; Hansjürgen T Agostini; H Kaspar Binz
Journal:  Angiogenesis       Date:  2012-09-15       Impact factor: 9.596

10.  Activation of Plant Innate Immunity by Extracellular High Mobility Group Box 3 and Its Inhibition by Salicylic Acid.

Authors:  Hyong Woo Choi; Murli Manohar; Patricia Manosalva; Miaoying Tian; Magali Moreau; Daniel F Klessig
Journal:  PLoS Pathog       Date:  2016-03-23       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.